Clinical trial
AndroGel in Men With Major Depression and Incomplete Response to Antidepressant…
NCT00304746 · Mclean Hospital, Other · Completed
Key facts
| NCT number | NCT00304746 |
|---|---|
| Title | AndroGel in Men With Major Depression and Incomplete Response to Antidepressant Treatment |
| Official title | A Parallel-Group, Placebo-Controlled Trial of AndroGel in Men With Major Depressive Disorder Who Display an Incomplete Response to Standard Antidepressant Treatment |
| Lead sponsor | Mclean Hospital, Other |
| Collaborators | Solvay Pharmaceuticals Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Depressive Disorder, Major |
| Intervention type | Drug |
| Interventions | Testosterone gel, Placebo |
| Enrollment | 100 |
| Start date | Apr 1, 2006 |
| Primary completion | Dec 1, 2008 |
| Completion | Apr 1, 2009 |
| First posted | Mar 20, 2006 |
| Last update posted | Nov 24, 2010 |
| Countries | Israel, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: